Teladoc Health, Inc.
NYSE:TDOCMedical - Healthcare Information Services
+$0.20 today
- Market cap
- $1.47B
- Beta
- 2.14
- P/E (TTM)
- -8.1
- EPS (TTM)
- -$0.96
Volume 3.96M
Average 4.68M
TDOC Other Non-current Assets
Long-term assets not reported separately.
Teladoc Health, Inc.NYSE: TDOC
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets falls 2.6% from a year ago
Other non-current assets stood at $106.04M at the end of Q1 FY2026, down 2.6% from a year earlier and down 23.0% from the prior quarter. Over 3 fiscal years it compounded at +20.6% a year.
Context
- Other non-current assets amounted to 3.8% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
- Other non-current assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -2.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 137.62M USD
- Year-over-year change
- +68.9%
- 4-year CAGR
- +60.6%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 137.62M | +68.9% |
| FY2024 | 2024-12-31 | 81.49M | +1.5% |
| FY2023 | 2023-12-31 | 80.26M | +2.2% |
| FY2022 | 2022-12-31 | 78.5M | +279.2% |
| FY2021 | 2021-12-31 | 20.7M | — |
Other Non-current Assets vs competitors
How TDOC compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -2.6% is the 6th highest of 10, against a peer median of -0.1%.
- Other non-current assets amounts to 3.8% of total assets for TDOC, versus a peer median of 2.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $106.04M USD | -2.6% | +20.6% | 3.8% | |
| Mar 2026 | $81.9M USD | +6.7% | +13.7% | 4.1% | |
| Apr 2026 | $61.08M USD | +1604.6% | +179.1% | 9.2% | |
| Sep 2026 | $54.63M USD | -37.3% | -8.1% | 3.2% | |
| Jun 2026 | $42.15M USD | +388.2% | +60.7% | 5.9% | |
| Mar 2026 | €37.33M EUR | -16.8% | -20.8% | 2.3% | |
| Mar 2026 | $11.2M USD | -22.7% | -1.7% | 1.4% | |
| Mar 2026 | $9.7M USD | -36.5% | +16.4% | 3.2% | |
| Sep 2026 | $7.18M USD | +50.7% | +119.8% | 1.4% | |
| Sep 2026 | $6.91M USD | -0.1% | +23.7% | 1.1% | |
| Sep 2026 | €0 EUR | — | — | 0.0% | |
| Peer median (excluding TDOC) | — | -0.1% | +16.4% | 2.7% | |
Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 893.48M | 918.18M | 1.12B | 1.3B | 781.08M |
| Short-term Investments | 2.54M | 0 | 0 | 0 | 0 |
| Net Receivables | 190.12M | 235.65M | 230.06M | 223.96M | 201.66M |
| Inventory | 73.08M | 56.34M | 29.51M | 38.14M | 38.2M |
| Other Current Assets | 27.96M | 12.1M | 40.15M | 36.02M | 2.07M |
| Total Current Assets | 1.23B | 1.29B | 1.49B | 1.66B | 1.09B |
| Property, Plant & Equipment (Net) | 74.01M | 71.47M | 72.09M | 56.58M | 53.09M |
| Goodwill | 14.5B | 1.07B | 1.07B | 283.19M | 283.19M |
| Intangible Assets | 1.91B | 1.84B | 1.68B | 1.43B | 1.3B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 355.6M | 0 | 0 | 242.5M |
| Other Non-current Assets | 20.7M | 78.5M | 80.26M | 81.49M | 137.62M |
| Total Non-current Assets | 16.51B | 3.42B | 2.9B | 1.85B | 2.01B |
| Total Assets | 17.73B | 4.7B | 4.39B | 3.52B | 3.1B |
| Account Payables | 47.26M | 47.69M | 43.64M | 33.13M | 47.97M |
| Short-term Debt | 0 | 13.59M | 0 | 550.72M | 11.04M |
| Tax Payables | 13.06M | 3.82M | 13.55M | 28.11M | 0 |
| Deferred Revenue | 75.57M | 101.83M | 95.66M | 79.3M | 62.31M |
| Other Current Liabilities | 132.21M | 151.28M | 167.26M | 108.69M | 187.17M |
| Total Current Liabilities | 331.01M | 399.77M | 420.62M | 941.54M | 404.74M |
| Long-term Debt | 1.23B | 1.54B | 1.54B | 991.42M | 994.92M |
| Deferred Tax Liabilities | 75.78M | 406.54M | 49.45M | 49.85M | 271.44M |
| Deferred Revenue (Non-current) | 3.83M | 11.95M | 13.62M | 9.79M | 9.14M |
| Other Non-current Liabilities | 10.78M | 1.62M | 1.08M | 720K | 643K |
| Total Non-current Liabilities | 1.36B | 1.99B | 1.65B | 1.08B | 1.31B |
| Total Liabilities | 1.69B | 2.39B | 2.07B | 2.03B | 1.72B |
| Common Stock | 160K | 163K | 167K | 173K | 178K |
| Retained Earnings | (1.42B) | (15.01B) | (15.23B) | (16.23B) | (16.43B) |
| Accumulated OCI | (6.29M) | (42.78M) | (36.99M) | (38.39M) | (34.73M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 16.05B | 2.31B | 2.33B | 1.49B | 1.39B |
| Total Debt | 1.28B | 1.59B | 1.59B | 1.58B | 1.04B |
| Net Debt | 386.65M | 668.74M | 468.6M | 286.29M | 259.08M |
Teladoc Health, Inc.
NYSE:TDOC
Intrinsic Alpha fair value
Locked
Current Price
$8.06
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.